Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ESSA Pharma Inc. Director's Dealing 2021

Mar 5, 2021

35249_dirs_2021-03-04_ca64e834-be3b-4817-90bf-e96d72008f8c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2021-02-22

Reporting Person: BERGER FRANKLIN M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-22 Common Shares P 57000 $27.00 Acquired 957244 Direct

More from ESSA Pharma Inc.

Regulatory Filings 2025
Nov 17
Major Shareholding Notification 2025
Nov 14
Major Shareholding Notification 2025
Nov 14
Regulatory Filings 2025
Oct 28
Director's Dealing 2025
Oct 15
Director's Dealing 2025
Oct 15
Director's Dealing 2025
Oct 15
Director's Dealing 2025
Oct 15
Director's Dealing 2025
Oct 15
Director's Dealing 2025
Oct 15
View all filings →